News | Digital Radiography (DR) | November 25, 2019

Lunit INSIGHT CXR will be presented at RSNA 2019 in AI Showcase, booth #10732

 Lunit INSIGHT CXR

A radiologist conducts an interpretation of a chest x-ray image with Lunit INSIGHT CXR analysis.


November 25, 2019 — Lunit announced the certification of CE mark for its most up-to-date chest X-ray analysis AI, Lunit INSIGHT CXR. The software provides analysis of chest x-ray images, detecting major findings that can lead to the most common lung diseases.

The CE mark enables the company to provide the AI solution to European healthcare institutions that conduct chest x-ray screenings, which is a widely-used method of basic imaging tests. According to the company, Lunit INSIGHT CXR is designed to help increase accuracy to detect more findings and alleviate the burden of radiologists who conduct routine chest x-ray interpretations.

“We are delighted to announce that one of our most mature products, Lunit INSIGHT CXR, has won CE marking,” said Brandon Suh, M.D., CEO of Lunit. “We look forward to installations among hospitals across Europe, where an improvement in healthcare services in the region can greatly impact many people’s lives.”

Lunit INSIGHT CXR detects 10 major chest abnormalities including nodule, calcification, pneumothorax, consolidation, fibrosis, and more, also supporting tuberculosis (TB) screening. The detection accuracy reaches at average 98.7 percent.

The AI analysis results are presented on the chest x-ray image, providing the location information and the abnormality score, which reflects the probability of the existence of the detected findings. The software also generates case reports that summarize the evaluation for each case, conducted by the AI.

According to Lunit, the software has been highlighted recently in major publications such as Radiology, Scientific Reports, JAMA Open Network, and Clinical Infectious Diseases. The publications validate the performance of Lunit INSIGHT CXR as well as its clinical value in an emergency department and TB screening setting.

“Lunit INSIGHT CXR has been evolving ever since its first introduction at RSNA 2017,” said Sunggyun Park, Ph.D., head of chest radiology at Lunit. “According to our reader study published in Radiology, our product can greatly improve reader performance by 20 percent at the highest. It can support radiologists to gain efficiency in the day to day workflow.”

The product is currently clinically installed for use in Mexico, UAE, China, Thailand and Korea. More than 2.3 million images from over 80 countries have been analyzed through a public demo of the software since its launch two years ago. The demo is publicly available at https://insight.lunit.io.

Lunit INSIGHT CXR will be presented at RSNA 2019, scheduled for Dec. 1-5 in Chicago. Lunit's booth will be located in AI Showcase, booth #10732. The demo will be also available at partner booths: FUJIFILM REiLi, GE Healthcare and INFINITT.

For more information: www.lunit.io


Related Content

News | Computed Tomography (CT)

April 2, 2026 — Nano-X Imaging Ltd. recently announced its U.S.-based subsidiary, Nanox Impact Inc., has signed a new ...

Time April 08, 2026
arrow
News | Computed Tomography (CT)

April 2, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for True ...

Time April 03, 2026
arrow
News | Ultrasound Imaging

March 30, 2026 — Butterfly Network, Inc. has received clearance from the U.S. Food and Drug Administration (FDA) for a ...

Time April 01, 2026
arrow
News | Computed Tomography (CT)

March 30, 2026 — HCA Healthcare’s Good Samaritan Hospital is the first hospital in the Bay Area to implement Lumina 3D ...

Time April 01, 2026
arrow
News | Radiology Business

March 31, 2026 — Radon Medical Imaging, a medical imaging equipment maintenance and repair services company, has has ...

Time March 31, 2026
arrow
News | Radiology Imaging

March 26, 2026 — GE HealthCare has announced a renewed research collaboration with Stanford Medicine Department of ...

Time March 30, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

March 25, 2026 A Penn Medicine–led team has developed a first‑of‑its‑kind artificial intelligence system that interprets ...

Time March 26, 2026
arrow
News | FDA

March 24, 2026 — MARS Bioimaging, a New Zealand–headquartered medical device company, has received U.S. Food and Drug ...

Time March 25, 2026
arrow
News | Cybersecurity

March 23, 2026 —Sacumen has launched ConnectX, a unified AI platform that gives cybersecurity product companies full ...

Time March 25, 2026
arrow
News | Pediatric Imaging

March 17, 2026 – OXOS Medical recently announced that its MC2 portable X-ray system is now cleared for pediatric imaging ...

Time March 23, 2026
arrow
Subscribe Now